Wellington Management Group LLP Has $136.12 Million Stock Holdings in Globe Life Inc. $GL

Wellington Management Group LLP decreased its position in shares of Globe Life Inc. (NYSE:GL) by 42.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 761,798 shares of the company’s stock after selling 561,683 shares during the quarter. Wellington Management Group LLP owned about 0.99% of Globe Life worth $136,118,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of GL. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life during the second quarter worth $28,000. Hilton Head Capital Partners LLC bought a new stake in shares of Globe Life in the 4th quarter valued at $30,000. MUFG Securities EMEA plc bought a new stake in shares of Globe Life in the 2nd quarter valued at $31,000. Johnson Financial Group Inc. acquired a new stake in Globe Life during the 2nd quarter worth $39,000. Finally, AdvisorNet Financial Inc raised its stake in Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after buying an additional 92 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Morgan Stanley boosted their target price on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Weiss Ratings lowered Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. TD Cowen lifted their price objective on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Piper Sandler boosted their price objective on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. increased their target price on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Globe Life currently has a consensus rating of “Moderate Buy” and an average price target of $191.67.

Insiders Place Their Bets

In other Globe Life news, EVP Michael Clay Majors sold 37,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total value of $6,609,680.00. Following the sale, the executive vice president owned 53,518 shares in the company, valued at approximately $9,560,455.52. The trade was a 40.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the transaction, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at approximately $9,004,053.60. This trade represents a 15.62% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 151,908 shares of company stock worth $27,239,981 in the last 90 days. Company insiders own 2.11% of the company’s stock.

Globe Life Trading Down 0.1%

GL opened at $172.59 on Tuesday. The stock has a market capitalization of $13.26 billion, a P/E ratio of 11.46 and a beta of 0.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The firm’s fifty day simple moving average is $178.78 and its 200 day simple moving average is $159.87.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the prior year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, research analysts anticipate that Globe Life Inc. will post 15.71 EPS for the current fiscal year.

Globe Life Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be issued a dividend of $0.33 per share. The ex-dividend date is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is presently 8.76%.

Globe Life declared that its Board of Directors has approved a stock buyback program on Monday, August 10th that allows the company to buyback $2.50 billion in shares. This buyback authorization allows the company to reacquire up to 17.7% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.